Official Journal of the European Behavioural Pharmacology Society (EBPS)

Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:

Human Psychopharmacology: Experimental

This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.

Human Psychopharmacology: Clinical and Translational

This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.

Preclinical psychopharmacology: Behavioral and Neural

This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.

Preclinical Psychopharmacology: Translational

This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.

Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic

This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.

The journal welcomes submissions in all of these fields.

Details Concerning the Submission and Publication Procedures:
- No Page Charges
- No Fees for Online Color Images
- Optional Color Images in Print – EUR 950/USD 1150. VAT or local taxes will be added where applicable.
- Optional Open Access Publication Fee (APC) - EUR 2990/USD 3760/GBP 2490. VAT or local taxes will be added where applicable.

  • Publishes research and reviews of mechanisms by which drugs affect behavior
  • Extends from clinical psychopharmacology to studies of effects of drugs on human cognition and behavior
  • Covers methodologies from neurochemical assays to functional neuroimaging studies

Journal information

Principal Editor
  • Diego Pizzagalli,
  • James Stone,
  • Debra Bangasser,
  • Mitul A. Mehta,
  • Kenji Hashimoto,
  • Stan B. Floresco,
  • Deepak Cyril D'Souza
Coordinating Editor
  • Trevor W. Robbins,
  • Christelle Baunez,
  • Patricia H. Janak
Publishing model
Hybrid (Transformative Journal). How to publish with us, including Open Access

Journal metrics

4.415 (2021)
Impact factor
4.312 (2021)
Five year impact factor
47 days
Submission to first decision (Median)
1,327,532 (2021)
Downloads

Latest articles

Journal updates

View all updates

Working on a manuscript?

Avoid the most common mistakes and prepare your manuscript for journal editors.

Learn more

About this journal

Electronic ISSN
1432-2072
Print ISSN
0033-3158
Abstracted and indexed in
  1. ANVUR
  2. BFI List
  3. BIOSIS
  4. Baidu
  5. Biological Abstracts
  6. CAB Abstracts
  7. CLOCKSS
  8. CNKI
  9. CNPIEC
  10. Chemical Abstracts Service (CAS)
  11. Current Contents/ Life Sciences
  12. Dimensions
  13. EBSCO Discovery Service
  14. EMBASE
  15. ERIH PLUS
  16. Gale
  17. Google Scholar
  18. IFIS Publishing
  19. Japanese Science and Technology Agency (JST)
  20. Journal Citation Reports/Science Edition
  21. Medline
  22. Meta
  23. Naver
  24. Norwegian Register for Scientific Journals and Series
  25. OCLC WorldCat Discovery Service
  26. Pathway Studio
  27. Portico
  28. ProQuest Animal Behavior Abstracts
  29. ProQuest-ExLibris Primo
  30. ProQuest-ExLibris Summon
  31. PsycINFO
  32. Reaxys
  33. SCImago
  34. SCOPUS
  35. Science Citation Index
  36. Science Citation Index Expanded (SCIE)
  37. TD Net Discovery Service
  38. UGC-CARE List (India)
  39. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer-Verlag GmbH Germany, part of Springer Nature